Pages

Sunday, October 13, 2019

FW: (LML) Request advice on a lepromatous patient treatment

 

Leprosy Mailing List – October 13,  2019

Ref.:  (LML)   Request advice on a lepromatous patient treatment

From:  Marivic Balagon, Cebu, Philippines


Dear colleagues,

 

Referring to the letter from Dr. Fernandez of October 7, 2019.

A combination of Rifampicin + Moxifloxacin + Minocycline is considered very effective. Considering the long doubling time of M.leprae ( 2 weeks), the monthly dose  is considered more practical than the daily dose. The recommendation is only daily or monthly dose. There shall be no in-between since molecular studies suggest that an in-between dose (every 2 weeks) may trigger mutation causing drug resistance.

 

Sincerely,

Marivic 

Dr Marivic Balagon

Executive Director

Leonard Wood Memorial Research for TB & Leprosy

Cebu City, Philippines 

 

 


 Luchamos todos unidos por un mundo sin lepra


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/bc04c9f1-7026-437b-95d9-bce66b3c4d12%40googlegroups.com.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.